Medical Research Advisory Committee

Professor Doug Hilton AO, BSc (Hons), PhD, FAA, FAHMS, FTSE

Chair of the ACRF Medical Research Advisory Committee

Appointed to the MRAC in 2008

Director, WEHI; Head, The Brain Cancer Centre; The Lorenzo and Pamela Galli Chair in Medical Biology; Professor of Medical Biology; Head, Department of Medical Biology and Honorary Principal Fellow, Department of Zoology, The University of Melbourne.

Professor Michael Brown MBBS, PhD, FRACP, FRCPA

Appointed to the MRAC in 2016

Director, Cancer Clinical Trials Unit, and Senior Consultant, Department of Medical Oncology, Royal Adelaide Hospital Cancer Centre; Clinical Professor, School of Medicine, The University of AdelaideAdjunct Professor, School of Pharmacy and Medical Sciences, University of South Australia; Head, Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology, Adelaide.

Professor David Cameron BA (Hons), DES, MA, MBBS, MSc, DES, MD, CCST, MRCP(UK), FRCPEd

Appointed to the MRAC in 2017

Professor of Oncology and Deputy Director of IHDP at the University of Edinburgh.

Professor Michelle Haber AM, BSc (Psych) (Hons), PhD, Hon DSc (UNSW), FAHMS, FAA

Appointed to the MRAC in 2012

Executive Director, Children’s Cancer Institute; Co-Theme Head, Molecular Targets and Cancer Therapeutics; Group Leader, Experimental Therapeutics; Conjoint Professor Faculty of Medicine, University of NSW.

Professor Geoff Hill MD

Appointed to the MRAC in 2008

Full Professor; José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research, Division Head and Senior Vice President, Scientific Director of The Immunotherapy Integrated Research Center and Director of Hematopoietic Stem Cell Transplantation, Fred Hutchinson Cancer Center; Professor of Medicine, Division of Medical Oncology, University of Washington.

Professor Philip Hogg BSc (Hons), PhD

Appointed to the MRAC in 2003

Director, ACRF Centenary Cancer Research Centre, Centenary Institute.

Professor Ricky Johnstone, PhD, FAHMS

Appointed to the MRAC in 2019

Executive Director Cancer Research, Peter MacCallum Cancer Centre; Professorial Fellow (Professor), The Sir Peter MacCallum Department of Oncology, University of Melbourne; Associate Director of Laboratory Research, NHMRC Senior Principal Research Fellowship, Assistant Director of Research, Co-Head, Cancer Therapeutics Program, Head of Gene Regulation Laboratory, Peter MacCallum Cancer Centre; Senior Fellow in the Department of Biochemistry, University of Melbourne.

Professor Paul Lambert BSc, PhD

Appointed to the MRAC in 2014

NCI Outstanding Investigator; Howard M Termin Professor and Chair, Oncology and Director, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health; Member, NCI Board of Scientific Counselors.

Professor Peter Leedman AO MBBS, PhD, FRACP, FAHMS

Appointed to the MRAC in 2019

Director, Harry Perkins Institute of Medical Research, WA; Professor of Medicine, University of WA.

Professor Angel Lopez AO MBBS, PhD, FRCPA, FAA

Appointed to the MRAC in 2014

Head of Human Immunology, SA Pathology, Adelaide.

Professor John Rasko AO, BSc (Med), MBBS (Hons), PhD, MAICD, FFSc(RCPA), FRCPA, FRACP, FAHMS

Appointed to the MRAC in 2016

Head of Department, Cell & Molecular Therapies, Royal Prince Alfred Hospital; Professor, Faculty of Medicine & Health, The University of Sydney; Head, Gene and Stem Cell Therapy Program, Centenary Institute; Senior Staff Specialist Haematologist, Sydney Cancer Centre, Royal Prince Alfred Hospital.

Professor Roger Reddel AO BSc (Med), MBBS, PhD, FRACP, FAHMS, FAA

Appointed to the MRAC in 2012

Director of Children’s Medical Research Institute

(CMRI), Westmead, Sydney; Sir Lorimer Dods

Professor, The University of Sydney; Head of CMRI’s Cancer Research Unit, Director of CellBank Australia and Co-Director of ProCan®

Professor Helen Rizos BSc (Hons1), PhD

Appointed to the MRAC in 2019

Professor, Cancer Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University.

Professor Clare Scott AM, MBBS, PhD, Melbourne FRACP

Appointed to the MRAC in 2019

Joint Division Head, Clinical Translation (Cancer), Laboratory Head, Cancer Biology and Stem Cells Division, Walter & Eliza Hall Institute; Chair, Gynaecological Cancer, Faculty of Medicine, University of Melbourne.

Professor Jennifer Stow BSc (Hons), PhD

Appointed to the MRAC in 2009

NHMRC Principal Research Fellow; Deputy Director (Research) and Group Leader, Cell Biology and Molecular Medicine Division, Centre for Inflammation and Disease Research, Institute for Molecular Bioscience, University of Queensland.

Professor Connie Trimble MD

Appointed to the MRAC in 2014

Professor, Department of Gynecology and Obstetrics; Department of Oncology; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, USA. Diplomate, American Board of Pathology, Diplomate, American Board of Obstetrics and Gynecology; Fellow of the American College of Obstetricians and Gynecologists.

Professor Mathew Vadas AO, BS, BSc(Med), PhD, DSc, FRACP, FRCPA, GAICD, FAHMS

Appointed to the MRAC in 1997, Chairman 2003-2007 Executive Director, Centenary Institute.

Professor.dr Sjoerd Van Der Burg PhD

Appointed to the MRAC in 2017

Sjoerd van der Burg is full professor in the Immunotherapy of solid tumors with emphasis on immunomonitoring. He heads the laboratory of Medical Oncology and leads the group of Experimental Cancer Immunology and Therapy at the Leiden University Medical Center, the Netherlands. He is also appointed as senior investigator at the Oncode Institute.

Dr Nic Waddell BSc, PhD

Appointed to the MRAC in 2022

Head of the Medical Genomics group and coordinator of the Cancer Program at QIMR Berghofer Medical Research Institute in Brisbane, Queensland; Member, Executive Committee for Australian Genomic Technologies Association; Member, Australian Genomics; Research Committee Member, Cure Cancer Australia; Member, Queensland Genomics Community Advisory Group; Co-founder and Board Member, genomiQa; Cancer Institute NSW Research Committee; Associate Member, Australian Academy of Health and Medical Science Mentoring Scheme.

Emeritus Professor Ian Frazer AC, MBChB (Edin), MD, FRS, FAA

Appointed to the MRAC in 2005, Chairman 2009-2017

Professor, School of Medicine, The University of Queensland; Head, Cancer Immunology Program, UQDI; Board Chair, TRI Foundation; Chair, Advisory Board, Medical Research Future Fund.